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 Right Upper-Quadrant Pain in a Patient 
with Drug Abuse, Secondary Syphilis and 
Occult Hepatitis B Virus  
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hepatitis and highlights the importance of obtaining a de-
tailed social history. Further, one should consider the pres-
ence of occult HBV and recognize the serologic pattern. 
 © 2014 S. Karger AG, Basel 
 Introduction 
 Acute hepatitis has many independent and concomi-
tant causes. When evaluating a patient with acute hepati-
tis, a clinician must investigate the most likely etiologies 
thoroughly. This case report chronicled the procedures 
that were followed to diagnose the causes of acute hepa-
titis in a patient with multiple potential causes.
 Case Report 
 A 40-year-old Caucasian man presented to the Emergency De-
partment in December 2012 with right upper-quadrant pain of 3 
weeks’ duration. His wife, who was present, had also noticed a yel-
lowing of his sclera and skin over this period. The pain had started 
as an ache in his right side and had gradually increased in inten-
sity to 8 on a severity scale of 0 to 10. No exacerbating or alleviating 
factors were identified. He reported a history of buprenorphine/
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 Abstract 
 Objective: To describe the etiology of hepatitis and identify 
occult hepatitis B virus (HBV) infection.  Clinical Presentation 
and Intervention: A 40-year-old man presented with severe 
abdominal pain and jaundice, a history of acute HBV infec-
tion that had cleared as well as the use of acetaminophen, 
methamphetamine, buprenorphine and marijuana. He ad-
mitted to having had unprotected sex with multiple partners 
of both genders. A thorough skin examination revealed pap-
ulosquamous lesions on his penis, scrotum, upper and lower 
extremities and feet. Transaminases and bilirubin were ele-
vated. His rapid plasma reagin was reactive, and hepatitis 
serologies showed occult HBV. Liver biopsy showed severe 
hepatitis, but the stains for hepatitis B surface antigen and 
hepatitis B core antigen were negative. The pathological 
findings were highly indicative of drug-induced hepatitis 
without evidence of chronic hepatitis, reactivation of HBV or 
syphilitic hepatitis. With supportive management and absti-
nence from drugs, his condition improved.  Conclusion: This 
case describes a patient with multiple potential causes for 
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naloxone use years ago, but initially denied recent use. He com-
plained of fatigue and malaise but denied experiencing nausea, 
vomiting, diarrhea, fever, chills or weight loss. He had not had 
contact with sick people or travelled recently. Tobacco, alcohol and 
intravenous drug use were initially denied. He claimed to be mo-
nogamous with his wife. He had worked as a welder for 15 years 
and had noticed some ‘burns’ on his upper extremities over the 
past few weeks and claimed he did not wear the proper protective 
clothing while welding. 
 The patient’s medical history was significant for an acute hepa-
titis B virus (HBV) infection 2 years previously. He claimed to have 
acquired this from a tattoo while in prison. His transaminases had 
normalized a month later, with the follow-up hepatic panel show-
ing clearance of the acute infection and he had been asymptom-
atic. He was negative for hepatitis C virus in 2010 and 2012, for the 
period tested. He did not keep his follow-up clinic appointments 
after his clinical improvement from the acute HBV. 
 The physical examination revealed a thin, disheveled man in no 
apparent distress. He was afebrile with normal vital signs. His skin 
was jaundiced with numerous nontender papulosquamous lesions 
with superficial scales of 0.5–1 cm in diameter on his upper ex-
tremities (including the palms of his hands) in various states of 
healing. He had scleral icterus, poor dentition and a nontender 
ulcerated lesion of 7 mm in diameter on his soft palate. The ab-
dominal examination revealed a tender, enlarged liver palpable to 
6 cm below the right costal margin. A genital examination was re-
fused by the patient. He was alert and oriented with no neurologic 
deficits or evidence of encephalopathy.  Figure 1 lists the pertinent 
laboratory investigations conducted. An abdominal ultrasound 
showed a ‘starry sky’ appearance of the liver with intra- and extra-
hepatic biliary ductal dilatation without obstructing stones or 
mass.
 Given the unusual skin and oral findings upon examination, 
additional history was taken from the patient when his family was 
not present. Although he had initially denied drug use, he eventu-
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Bilirubin, T
October 2010 November 2010 December 2012 May 2013  
HBsAg Positive  Negative Negative Negative 
Anti-HBs Negative Positive  Positive  Positive  
Anti-HBc Positive  Positive  Positive  Positive  
Hepatitis B 
DNA
>110,000,000 IU/ml   Detected, but not
quantified (<41 IU/ml) 
Not detected  
Anti-HCV Negative  Negative  
HIV antibody Nonreactive  Nonreactive  Nonreactive  Nonreactive  
 
 Fig. 1. Laboratory findings. Alk phos = Alkaline phosphatase; ALT = alanine aminotransferase; Anti-HBc = hep-
atitis B core antibody; Anti-HBs = hepatitis B surface antibody; Anti-HCV = hepatitis C antibody; AST = aspar-
tate aminotransferase; HBsAg = hepatitis B surface antigen. 
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ally admitted to using methamphetamine, oxycodone/acetamino-
phen, buprenorphine and marijuana regularly and concomitantly 
over the past year. He reported a 20-year history of intravenous 
drug use that had ended 3 years previously. He admitted to having 
unprotected sex with multiple partners of both genders. He had 
noticed an enlarged inguinal lymph node (approximately 3 cm in 
diameter) a month before presentation that had resolved without 
ulceration. He then allowed for a more thorough skin examina-
tion, and we discovered similar papulosquamous lesions on his 
penis, scrotum, lower extremities and feet. Considering the new 
insight into his social history, more laboratory tests were collected. 
The patient’s rapid plasma reagin was reactive with a titer of 1: 512. 
Treponema pallidum particle agglutination was reactive as well. 
His wife was informed about this result, and she tested negative for 
syphilis. Acute HIV infection was suspected, but HIV antibody 
and quantitative viral load were not detected. Cytomegalovirus 
IgM and IgG antibodies were positive. The autoimmune hepatitis 
panel was negative and so were antibodies to hepatitis A, C, D and 
E. The differential diagnosis for his acute hepatitis included reac-
tivation of HBV, syphilitic hepatitis, Cytomegalovirus hepatitis 
and drug-induced hepatitis.
 The hepatitis B panel was not indicative of acute infection since 
the hepatitis B surface antigen was negative. A percutaneous liver 
biopsy was obtained (fig. 2). Severe Kupffer cell hypertrophy, marked 
ballooning degeneration of hepatocytes and centrilobular necrosis 
were present. Immunohistochemical stains for hepatitis B surface 
antigen and hepatitis B core antigen were negative. No spirochetes 
or granulomatous changes were seen. These pathologic findings 
were highly indicative of drug-induced hepatitis without evidence of 
chronic hepatitis, reactivation of HBV or syphilitic hepatitis.
 The patient was given two doses of intramuscular penicillin G 
benzathine of 2.4 million units and counseled to refrain from drug 
use and unprotected sexual contact. When his transaminases be-
gan trending down and his pain resolved, he was discharged home. 
He presented to the Infectious Disease Clinic for a 6-month follow 
up in May 2013 with a 64-fold decline in rapid plasma reagin titer 
to 1: 8. HBV DNA was not detected, and his serologies indicated 
immunity. A urine drug screen showed no illicit drug use, and he 
claimed to have abstained from sexual contact for the past 6 
months. A final diagnosis of drug-induced acute hepatitis from 
methamphetamine, oxycodone/acetaminophen and buprenor-
phine in the setting of secondary syphilis and an occult HBV infec-
tion was made.
 Discussion 
 This interesting case chronicled the diagnostic process 
for a patient with a number of potential causes of acute 
hepatitis, demonstrating the importance of avoiding pre-
mature closure, which is the most common cognitive er-
ror when establishing a diagnosis  [1] . In immunocompe-
tent adults with acute HBV infection, 95% spontaneously 
develop seroclearance of HBsAg, which indicates reso-
lution of acute infection. Despite this clearance, small 
amounts of viral DNA may still be detected in the serum 
by PCR, demonstrating an inactive residual phase of in-
fection  [2] . Quantitative detection of HBV DNA is made 
typically by real-time PCR amplification and the detec-
tion of its genomic DNA being compared to a quantita-
tive standard. The quantitative range for detection of this 
assay at our reference laboratory is 20–170,000,000 IU/
ml. Given the multiple symptoms and medical history of 
our patient, our initial leading diagnosis was a reactiva-
tion of HBV. However, the serologies did not support an 
active HBV infection and the patient’s social history and 
physical exam suggested additional etiologies. His hepa-
titis panel was consistent with an occult HBV infection 
since his hepatitis B surface antigen was negative. HBV 
DNA was detectable but too low for quantification by 
PCR, and hepatitis B core antibody and hepatitis B sur-
face antibody were positive  [2, 3] . However, occult HBV 
is usually asymptomatic and is only detected when testing 
for other reasons such as sexually transmitted infections, 
immunosuppression or when considering therapy for 
hepatitis C virus  [4] . Areas for further research include 
identifying the prevalence and infectivity of occult HBV 
and the role it plays in fibrosis formation.
 Secondary syphilis is a rare cause of hepatitis, usually 
with a mild clinical presentation. The typical findings are 
mildly elevated transaminases, normal or mildly elevated 
a b
 Fig. 2.  a Trichrome-stained low-power 
view of periportal fibrosis with inflamma-
tion.  b High-power view of severe hepatitis 
with mixed inflammatory infiltrate of 
mostly lymphocytes and neutrophils, but 
eosinophils and plasma cells were also 
identified. 
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bilirubin and a disproportionately high serum alkaline 
phosphatase level  [5] . Our patient’s acute illness was not 
consistent with these levels, and his liver biopsy did not 
reveal spirochetes or granulomatous changes. However, 
in a large number of cases, there is no visualization of spi-
rochetes or noncaseating granulomas on biopsy  [6] .
 Drug-induced hepatic toxicity is the most common 
cause for withdrawing a drug from the market  [7] . Our 
patient showed evidence of two active mechanisms of 
 hepatic injury: direct hepatocellular toxicity and cholesta-
sis. He admitted to taking acetaminophen, methamphet-
amine and buprenorphine, all of which are known to de-
plete glutathione levels, leaving hepatocytes susceptible 
to oxidative damage which prevents mitochondria from 
synthesizing adenosine triphosphate, resulting in necro-
sis  [8, 9] . However, hepatic damage by amphetamines is 
most commonly seen with methylenedioxymethamphet-
amine (Ecstasy). Because of the unregulated manufactur-
ing of illicit substances, such as methamphetamine, a pa-
tient may also be at risk of ingesting hepatotoxic contam-
inants  [10] . Withdrawal of the offending agent(s) and 
supportive care is the treatment of choice for drug-in-
duced hepatitis. We would like to note that a major limi-
tation of this report was the sporadic follow-up appoint-
ments.
 Conclusion 
 This case highlighted the diagnostic process for a pa-
tient presenting with multiple potential causes for abdom-
inal pain as well as the importance of taking a detailed 
social history. Further, one should consider the presence 
of occult HBV and recognize the serologic pattern. Our 
patient’s presentation of secondary syphilis was compel-
ling, but it was the pathology and laboratory results that 
assisted us in making the diagnosis of drug-induced hepa-
titis being the most likely cause of his symptoms.
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